Are the proprotein convertase subtilisin/kexin type 9 inhibitors new therapeutic chance for patients with familial hypercholesterolaemia and liver failure?
published in: European Heart Journal
date of publication: 2018-07-01
Cites articles
There is nothing here
Article - wd:Q89263064